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Aim:  To  discuss  the  broad  evidence  base  on  which  strategies  to enhance  the  early  detection  and  diagnosis
of oral  cancer  and  potentially  malignant  disorders  (PMD)  should  be designed.
Methods:  We  reviewed  the  evidence  for current  oral  mucosal  screening  approaches  and  used  a theoretical
model to explore  behavioural  inﬂuences  on  the  early  detection  of oral  cancer,  and  to  outline  strategies
for  future  interventions  and  research.
Results:  While  considerable  advances  are  being  made  in  techniques  to  detect  oral  cancer,  there  has  been
less  attention  paid  to  the  patient  and  health  care  provider  factors  which  may  inﬂuence  delays  in detection
of oral  cancer.  This  review  proposes  that  unless  future  theory  based  studies  target  these  aspects  of  oral
cancer,  then  efforts  to improve  its timely  detection  will have  limited  effectiveness.
Conclusions: A  primary  tenet  of  screening  programs,  whether  opportunistic,  targeted  or  population  based
is that  at-risk  people  present  for  screening.  They  must  also  present  early  enough  in  the  disease  process
for detection  to lead  to  a better  outcome.  This  is  particularly  relevant  for oral  cancer.  Five-year  survival
rates have  not  improved  over  past  decades  and  this  has  mainly  been  attributed  to delays  in  detection.
Early  detection,  diagnosis  and  treatment  signiﬁcantly  enhance  survival  rates  and reduce  morbidity.
© 2013 The Authors. Published by Elsevier Ltd. 
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1. Introduction
Squamous cell carcinoma of the oral cavity (oral cancer)
accounts for approximately 3% of all cancers worldwide [1].
The highest incidence rates occur in three developing countries
(Pakistan, Brazil and India) and one developed country (France).
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ecognised risk factors are tobacco smoking and alcohol consump-
ion. Betel quid and smokeless tobacco chewing are also important
isk factors in some populations, [2] and human papillomavirus
HPV) infection appears to be a risk factor for younger populations
3]. Although the oral cavity is a potentially accessible site for exam-
nation, up to 50% of oral cancers are not detected until the disease
s well advanced [4]. Screening may  assist with early detection and
mprove patient outcomes. Cancers of the oropharynx have similar
isk factors to those of oral cavity cancer and the term head and
eck squamous cell carcinoma (excluding nasopharyngeal cancer)
s commonly used to deﬁne cancers of the oral cavity and orophar-
nx [5]. This review focuses primarily on oral cavity cancer as it is
he most commonly occurring type [1] and is also the most acces-
ible site for screening.
Oral cancer is therefore a public health problem which carries
igniﬁcant morbidity and mortality [6]. While to date biomedical
esearch has informed most research and health interventions in
his area, it is important that the structural and social determinants
f this disease are also recognized and addressed. Without a com-
rehensive understanding of these factors, efforts to prevent, detect
nd manage diseases such as oral cancer are likely to be ineffective
n terms of outcomes and use of resources. This review therefore
ims to discuss the broad evidence base on which strategies to
nhance early detection of oral cancer should be designed. Firstly,
he evidence for current screening methods and approaches will
e reviewed. Secondly, this report will describe the growing body
f work exploring the psychosocial inﬂuences on early detection of
ral squamous cell carcinoma and potentially malignant disorders
PMD) [7]. In this review, the term ‘psychosocial’ refers to inter-
ctions between the social structures and context of an individual
nd their psychological characteristics, and which in turn inﬂuence
ealth behaviours and outcomes [8]. Based on this, strategies tar-
eting these inﬂuences will be discussed. Finally, areas in need of
urther research will be identiﬁed.
. Screening
.1. Current detection methods and approaches
A thorough mucosal examination should form part of a rou-
ine dental examination. Conventional oral examination has been
hown to have high discriminatory ability [9] and is the currently
ccepted practice for the detection of oral cancer and PMD. Detec-
ion of lesions may  be enhanced by the use of adjunctive aids
uch as toluidine blue, diffused white light, chemiluminescence or
oss of tissue autoﬂuorescence [6]. Research is continuing into the
ffectiveness of these and other aids [10–12] however as yet there
s insufﬁcient evidence to justify their use as screening adjuncts
13,14]. An important consideration though is how factors such as
he experience and conﬁdence of the practitioner and the accep-
ance of the patient of the procedures inﬂuence their effectiveness.
Oral cancer screening has been deﬁned as ‘the process by which
 practitioner evaluates an asymptomatic patient to determine if he
r she is likely or unlikely to have a potentially-malignant or malig-
ant lesion’ [15]. This may  occur as ‘population based screening’,
hen a population is assessed speciﬁcally for the purpose of detec-
ing oral cancer, as ‘opportunistic screening’, when patients who
re attending a health care provider for another purpose are exam-
ned for signs of oral cancer or PMD, or as ‘targeted screening’
hen high risk individuals are selected for screening [16]. In any
f these contexts, along with a visual and tactile examination of
he oral mucosa, the practitioner should ask the patient about their
ealth history including tobacco and alcohol use. The risk of oral
ancer is increased with age, alcohol and tobacco use and a his-
ory of upper aerodigestive tract cancer (reviewed in Ref. [15]). Theer Policy 1 (2013) e2– e7 e3
term ‘oral cancer screening’ in this review will be deﬁned as an oral
mucosal examination together with an assessment of the individ-
ual’s health history, including symptoms and risk factors. Clearly,
oral cancer screening is only one component of a comprehensive
‘oral examination’.
A 2010 Cochrane review [16] assessed the effectiveness of cur-
rent screening methods in reducing oral cancer. Only one study
met  the inclusion criteria. This study commenced in Kerala, India in
1995 and involved over 190,000 participants in 13 clusters [17,18].
The Kerala RCT, was a population based screening program and
the single randomized controlled trial conducted to date. This trial
demonstrated a stage shift such that cases were identiﬁed at an ear-
lier stage in the screened group compared with the control group.
Signiﬁcant methodological limitations leading to a high risk of bias
were identiﬁed by the Cochrane review with the design of this RCT.
These limitations included lack of detail regarding random assign-
ment of clusters, small number of clusters, no analysis of the effect
of clustering on the results, no blinding of the outcome assess-
ment and lack of information about withdrawals and drop-outs.
In addition, only 63% of participants with positive screen results
complied with referral and a low proportion of lesions were biop-
sied for histological conﬁrmation of diagnosis. The authors of the
review concluded that while there was  some evidence from the sin-
gle included study that visual examination as part of a population
based screening program reduced oral cancer mortality for high
risk individuals, further well designed RCTs were needed. While
RCTs represent the highest level of evidence for assessing the efﬁ-
cacy of an intervention, whether this type of study design is the
most appropriate way to determine the usefulness of screening for
oral cancer is debatable. The lack of rigorous trials is likely due to
feasibility and cost issues related to the very large sample sizes
required because of the relatively low incidence of oral cancer in
the general population [19]. Using diagnosis of oral cancer (cancer
registry data) as the outcome measure requires a long duration of
follow up (the Kerala trial used a nine year follow up) so that data
can be collected from a control group. It also assumes that cancer
registry data is complete and accurate. An RCT study design clearly
also raises ethical issues of withholding the screening from control
participants. A more appropriate way of answering this particular
question may  be to use modelling, although gaps in current knowl-
edge regarding malignant transformation rates and self-referral
patterns mean that currently there are limitations to this approach
[20].
A free screening clinic in the USA reported that suspicious
lesions were found in 5% of patients, and 1% of patients were
conﬁrmed to have oral cancer or PMD  [21]. The authors con-
cluded that due to the low prevalence of oral cancer, screening
should be targeted to high-risk groups. A surprising ﬁnding from
this study was  that half the patients with conﬁrmed malignan-
cies did not return for follow-up treatment. So while population
based screening cannot currently be recommended due to lack of
available evidence, further research should focus on targeting high
risk groups such as Australian Indigenous populations. In addition,
research to explore the psychosocial factors inﬂuencing outcomes
of screening programs and patient experience and understanding
of cancer diagnosis is urgently required.
The objective of early detection in oral cancer is to recognise
not only oral cancer but PMD  at the earliest possible stage. Refer-
ral of these lesions to a specialist will result in an early deﬁnitive
diagnosis and treatment if indicated. Even though accurately pre-
dicting malignant transformation for PMDs displaying dysplasia is
not currently possible, these lesions require special attention and
particular management strategies depending on the site, grade of
dysplasia and patient risk [22].
The value of screening programs may  not be solely limited to
the detection of oral cancer. Screening opportunities should also
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e utilised to improve patient awareness about the relationship
etween risk factors such as alcohol and tobacco and oral cancer,
hich may  play a role in prevention [23]. Any health promotional
spect of the screening should however be implemented in a way
hat is appropriate and acceptable to the target population.
. High risk groups
Populations at high risk of developing oral cancer are predomi-
antly older, male, heavy users of alcohol and tobacco, and have a
oor diet and low socioeconomic status [24]. Since the prevalence
f disease is higher in these groups, opportunistic screening pro-
rams targeted to these populations may  have greater effectiveness
16]. The cost effectiveness of this approach has been supported
y the results of a study using a simulation model [20] as well as
he Kerala trial [25]. An increase in the incidence of HPV-related
ral cancers however means that the demographics of the high
isk patient are likely to change or perhaps dichotomise, as these
esions are diagnosed at younger ages than HPV-unrelated oral
ancers [3]. An additional risk factor particular to South Asian cul-
ures is the chewing of areca nut and betel quid (with or without
obacco). These products are inexpensive and addictive and their
se is widespread and starts at an early age [26]. People from these
ultures, either residents in their home country or migrants to other
ountries, also represent a high risk group for whom screening
rograms may  be effective. There are however social and cultural
actors (religion, perceived health beneﬁts, ﬁrst or second gener-
tion immigrants) which inﬂuence the use of these products [26]
nd the risk of oral cancer so these factors should be further inves-
igated.
Other racial groups including African-Americans, [27] Hispan-
cs in New York [28] and Indigenous Australians [29] have also
een shown to have a higher prevalence of oral cancer and this
s probably largely due to increased smoking and alcohol use and
ower socioeconomic status of these groups. People in developing
ountries have higher rates of oral cancer and this has been sug-
ested to be due to greater exposure to risk factors and from an
arlier age [2]. Low socioeconomic status itself however has been
igniﬁcantly associated with oral cancer risk in both developing and
eveloped countries and this association remained after adjusting
or known risk factors (alcohol, smoking, diet low in fresh fruits
nd vegetables and HPV infection) [24]. While the reasons for this
re not yet fully understood, low levels of education and income
re likely to affect access to health care, nutrition, living and work-
ng conditions and life chances resulting in poorer health generally.
here has also been a suggestion that the stresses associated with
eprivation may  alter the molecular biology of cancer and this also
equires further investigation [24].
. Who  should screen?
There is an expectation that mucosal examinations are per-
ormed by dentists for all patients at dental examinations [6].
ppropriately trained dental auxiliaries could also carry out oppor-
unistic screening and this may  increase its cost effectiveness and
rovide health promotion opportunities. Indeed, auxiliaries have
lready been used in population based screening programs. Health
orkers who had received a 6 week training program performed
isual oral cancer examinations on 2069 of the Kerala RCT partic-
pants resulting in a sensitivity of 94.3% and a speciﬁcity of 99.3%
hen referenced to re-examination by a physician [30].
Unfortunately, those most at risk are unlikely to be regular
ental attendees [31] and this reduces the effectiveness of oppor-
unistic screening during dental visits. It has been shown that the
reater the risk of oral cancer the less likely the patient attended forr Policy 1 (2013) e2– e7
regular dental examinations [31]. This was especially the case for
smokers. This has been described as the ‘inverse screening law’ and
suggests that individuals who have risk behaviours such as heavy
drinking and smoking would be unlikely to exhibit risk aversion
behaviours such as preventive health visits.
While at-risk patients are irregular dental attendees, they may
visit their doctors, so general medical practitioners should also be
involved in screening this population for oral cancer. This does not
routinely occur [32] and this may  be due to doctors not feeling
conﬁdent in their knowledge of oral cancer and oral examination
techniques [33]. In a survey of UK general medical practitioners,
97% of respondents indicated that they had never had any education
in oral pathology and so it is not surprising that they felt that they
should leave oral cancer screening to dentists [34]. Patients with
symptoms of oral cancer tend to seek the advice of doctors rather
than dentists [35] and in a US study patients stated that they would
rather discuss oral cancer with their doctor than their dentist [36].
Doctors were the source of greater numbers of appropriate referrals
to specialists than dentists in a number of studies [35,37,38].
There is also a case to be made for patients to examine their own
mouths regularly, although a leaﬂet was  shown to be ineffective in
providing instructions on how to do this with sufﬁcient accuracy
[39].
5. Delays in detection and diagnosis
Theoretical models are important in understanding health
behaviours such as those inﬂuencing delays in detection of oral
cancer. They also provide a framework for the identiﬁcation of tar-
gets for interventions [40]. The use of a robust and generalisable
model also allows consistency of reporting and improved compara-
bility across studies. Recently, a model [41] has been proposed that
describes the delays that occur in the detection, diagnosis and treat-
ment of cancers, including those of the head and neck. This model
comprises four time intervals that together make up the total time
between the appearance of signs or symptoms of a cancer and the
commencement of treatment. These intervals are: appraisal; help-
seeking; diagnostic; and pre-treatment. The model is an evidence
based reﬁnement of the Andersen model of total patient delay [42].
Although there is a paucity of application of theoretical frameworks
in the area of cancer diagnosis and delay research, the Anderson
model, ﬁrst reported in 1995, [42] is amongst the most widely
cited [41]. The term ‘delay’ is commonly used in the literature but
is rejected in the current model since it implies blame and fails
to recognise the role of lesion factors (site, size, growth rate) and
health system factors (availability, cost, effectiveness, responsive-
ness) [41,43]. While this model explains the processes that begin
with a patient recognising symptoms, we  have used the time inter-
vals to also apply to asymptomatic oral lesions able to be detected
through opportunistic screening.
5.1. Appraisal
The appraisal interval is the period of time from when the
patient ﬁrst recognises their symptoms and begins to interpret
them up until they perceive that they should consult with a health
care provider [41]. Most patients have little knowledge of oral can-
cer and its associated risk factors and so may  ignore small painless
lesions [44] however symptoms of PMD  are reported to be re-
interpreted if they persist or progress [45]. Minor symptoms or
the absence of a lump have been found to elicit a lack of concern
and this has been shown to be relevant for breast cancer symp-
toms also [46]. One study found that it was not the nature of the
symptoms but rather the cognitive and emotional responses to
those symptoms, along with the patient’s context and beliefs that
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Both general dentists and general medical practitioners [68]
appear to require additional training to increase their conﬁdenceP.J. Ford, C.S. Farah / Journal o
nﬂuenced the decision to seek help [44]. It has been suggested that
atients do not want to bother the doctor or dentist with something
hey think is trivial [44,47]. Patients may  also try over-the-counter
herapies before deciding that they need to consult a health care
rovider [48]. Thirty percent of patients wait for three months
r more before seeking help [49]. These barriers to the timely
etection of lesions lead to poorer outcomes and reduced survival
ates [50].
.2. Help-seeking
The help-seeking interval commences when the patient ﬁrst
elieves they should seek help and ends at their ﬁrst consulta-
ion with a health care professional [41]. Patients who are normally
earful of dental visits may  have an added barrier to attend to seek
dvice from a dentist for their symptoms of oral cancer. Having
n existing appointment or needing to attend for another reason
routine check or another problem) was found to be a trigger for
elp-seeking [44]. Competing responsibilities, cost and access to
ealth care have also been shown to inﬂuence the patient’s decision
n whether or not to seek help [44].
.3. Diagnostic
This interval is from the time the patient ﬁrst presents to the
ealth care provider until the diagnosis is made [51]. This is where
atients with asymptomatic lesions that are potentially able to be
etected through opportunistic screening would enter the model’s
athway.
Dentists appear to do regular oral cancer examinations for their
atients but not in a systematic way. Potentially malignant lesions
ere found to be less well recognised than frank malignancy [43].
eassuringly though, dentists referred when in doubt about a lesion
52]. Dentists reported difﬁculty in explaining to patients that they
ad a potentially malignant lesion because of the lack of a deﬁnitive
iagnosis [53]. A survey of Spanish dentists found that 95% felt that
hey were qualiﬁed to screen but only 50% felt that their knowledge
nd training were up to date [54].
The diagnostic interval was found to be increased for smaller
ized lesions [55] and ulcerated lesions perhaps because deﬁni-
ive diagnosis is more difﬁcult [51]. Conversely, painful lesions and
hose with a signiﬁcant swelling were referred for diagnosis more
apidly [51]. Early diagnosis of oral pre-cancerous lesions is partic-
larly challenging because it requires practitioners to be familiar
ith the range of clinical presentations of PMDs, many of which
ay  resemble less serious conditions [56].
While dentists have more training in oral medicine and oral
athology than doctors, they have been shown to focus their exami-
ation on tooth or denture related tissues, rather than on higher risk
ites such as the ﬂoor of the mouth [57]. Dentists may  be slower to
efer than doctors because they may  try approaches such as adjus-
ing dentures or adjacent teeth ﬁrst [58]. Doctors on the other hand
re less familiar with oral lesions and so may  be more likely to refer
mmediately. One UK study [35] found that of the 100 oral cancer
atients they examined, only 54% had been referred (by general
ental or medical practitioners) directly to the specialist unit. Those
atients who were referred via an indirect route had an increase in
ength of the diagnostic interval.
A longer diagnostic interval has been shown to contribute to
isease progression and consequently to poorer prognosis [49].
t may  also have medicolegal implications [59]. Poor knowledge
nd conﬁdence of practitioners in screening and referral of sus-
icious lesions appear therefore to be signiﬁcant, but modiﬁable,
egative inﬂuences in the early detection and diagnosis of oral
ancer.er Policy 1 (2013) e2– e7 e5
5.4. Pre-treatment
This time interval is from the diagnosis to the start of treatment
and may  be inﬂuenced by patient, health system and lesion factors
[41]. Investigation of this type of delay, while important, is outside
the scope of this review.
6. Strategies
Interventions to promote the early detection of oral cancer must
be evidence based, and increasingly this evidence is grounded in
health behaviour theory [60]. Determinants of behaviour (patient
and practitioner) are obvious targets for interventions.
6.1. Patient awareness
Improving patient awareness of oral cancer would be predicted
to shorten the appraisal interval. Patients’ knowledge of oral cancer
compared to other types of cancer is low [61]. Patients in a US study
reported that they had rarely heard about oral cancer and many had
never had an oral cancer exam [36]. It is likely that these patients
had actually had an oral cancer screen but that their dentist had
not mentioned it. Dentists should therefore explain what they are
doing and take the opportunity to provide information about oral
cancer and its risk factors at routine dental visits.
There have been a number of examples where oral cancer
awareness has been enhanced, however whether this resulted in
earlier help-seeking has not been determined. A recent theory
based study found that a group at high risk for oral cancer wanted
not only more information on the symptoms of oral cancer, but
also guidance on how to evaluate symptoms [62]. A consumer led
media campaign in West Scotland was successful in improving
awareness about oral cancer including its symptoms and when to
seek help [63]. A social marketing campaign using diverse and cul-
turally appropriate approaches was effective in attracting people
from a high risk population to attend for oral cancer screening [64].
Even methods as simple as a leaﬂet however have been shown to
enhance long term knowledge of oral cancer, especially for young
adults [65]. Direct to consumer advertising of oral cancer screening
devices by the companies that sell them to dentists may  raise
awareness but appropriate controls need to be in place to ensure
that the information and advice given is appropriate and accurate
[66]. More research is required to determine the approaches that
will work best, and this will necessarily vary for different contexts.
Health promotion messages should convey information that
helps patients know when to consult their health care professional.
It has been suggested that a 2–3 week rule should be introduced
for high risk patients [44]. Any oral lesion lasting for greater than 2
weeks after local possible causative factors are removed should be
biopsied or referred without delay. This would reduce the misat-
tribution of symptoms and reassure patients that their health care
provider wants to see them if they have a lesion that persists for
more than 2 weeks. This concept worked for encouraging timely
treatment for myocardial infarction [67].
6.2. Practitioner trainingand consistency in undertaking oral cancer examinations and in
talking with their patients about their tobacco and alcohol use
[33,69–72]. Appropriate and accessible continuing education pro-
grams in this area are clearly needed.
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.3. Health system and policy
Since low socioeconomic status is a risk factor for oral cancer,
ttempts to address this health inequity should occur at a govern-
ent policy level and focus on improved access and affordability of
ealth care [73]. Services to assist with patient communication and
he navigation of the health system should also be provided [74].
. Recommendations for future research directions
There are clearly gaps in our current understanding of the inﬂu-
nces of early detection and diagnosis of oral cancer. The following
re suggestions for the future direction of research activities aimed
t enhancing the early detection and diagnosis, and ultimately sur-
ival, of oral cancer.
Recognise the critical need for an interdisciplinary approach to
not only health care, but also research.
Evaluate the outcomes and effectiveness of opportunistic
screening for high risk populations such as low socioeconomic
status, migrant and indigenous communities.
Investigate the barriers and triggers to attending for examination
for these high risk populations and consider innovative methods
of engaging with non attenders.
Evaluate new models of care incorporating oral health thera-
pists for oral cancer screening. These practitioners have expertise
in risk assessment and health promotion, which may  be under-
utilised.
Evaluate patient and clinician acceptability of new detection
technologies.
Explore the experiences and support needs of patients with PMD.
What factors are important in assisting patients to comply with
review appointments, treatment and behaviour change?
Investigate the most effective and appropriate ways of raising
public awareness of oral cancer and its risk factors.
Examine medical and dental university curricula to ensure that
the oral medicine and oral pathology component, particularly
in relation to head and neck cancer examination, matches with
graduate competencies.
Investigate what the professional organisations in oral medicine,
oral pathology, and head and neck oncology, are doing/could do
in terms of public awareness campaigns, practitioner education,
and policy development to enhance the early detection of oral
cancer.
. Conclusions
Due to the relatively low prevalence of oral cancer in most com-
unities and the absence of rigorously designed and implemented
CTs, there is currently insufﬁcient evidence to support population-
ased screening programs. Alternative approaches should include
argeting high-risk populations and adoption of opportunistic
creening programs. These approaches may  have limited effec-
iveness however if screening is not consistently or appropriately
ffered, or if patients do not access it. Barriers to the early detection
f oral cancer should be explored from the perspective of both the
atient and the health care provider. While opportunistic screening
s thought to be performed routinely by general dental practition-
rs and possibly by some general medical practitioners, whether
his is the case and how this is undertaken has not been thoroughly
xamined. Additionally, even if health care providers offer appro-
riate screening, the success of lesion detection is dependent upon
atient presentation and consent to an oral mucosal assessment.
hile there is a growing body of research investigating detec-
ion technologies and new therapies, the psychosocial research
[
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into how these new developments may  be accepted and utilised
is also urgently required. A limited but valuable body of research to
date has addressed factors inﬂuencing early detection of oral cancer
lesions. It is timely then, that as we  forge ahead with studies exam-
ining new diagnostic technologies for the early detection of oral
cancer and PMD, that we  also take the opportunity to look beyond
the clinical and molecular aspects of this disease, and consider the
structural and psychosocial parameters that surround it.
Conﬂict of interest statement
The authors have no conﬂicts to declare.
References
[1] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Cancer incidence
and mortality worldwide: IARC CancerBase No. 10. Lyon. France: International
Agency for Research on Cancer; 2008.
[2] de Camargo Cancela M,  Voti L, Guerra-Yi M,  Chapuis F, Mazuir M,  Curado MP.
Oral cavity cancer in developed and in developing countries: population-based
incidence. Head and Neck 2010;32(March (3)):357–67.
[3] Chaturvedi AK, Engels EA, Anderson WF,  Gillison ML.  Incidence trends for
human papillomavirus-related and -unrelated oral squamous cell carcinomas
in  the United States. Journal of Clinical Oncology 2008;26(February (4)):612–9.
[4] McGurk M,  Chan C, Jones J, O’Regan E, Sherriff M.  Delay in diagnosis and its effect
on outcome in head and neck cancer. British Journal of Oral and Maxillofacial
Surgery 2005;43(August (4)):281–4.
[5] Argiris A, Karamouzis MV,  Raben D, Ferris RL. Head and neck cancer.
Lancet 2008;371(May (9625)):1695–709 [research support, N.I.H., extramural
review].
[6] McCullough MJ,  Prasad G, Farah CS. Oral mucosal malignancy and potentially
malignant lesions: an update on the epidemiology, risk factors, diagnosis and
management. Australian Dental Journal 2010;55(June (Suppl. 1)):61–5.
[7] van der Waal I. Potentially malignant disorders of the oral and oropharyngeal
mucosa; terminology, classiﬁcation and present concepts of management. Oral
Oncology 2009;45(Apr–May (4–5)):317–23.
[8] Martikainen P, Bartley M,  Lahelma E. Psychosocial determinants of health in
social epidemiology. International Journal of Epidemiology 2002;31(December
(6)):1091–3.
[9] Moles DR, Downer MC,  Speight PM.  Meta-analysis of measures of performance
reported in oral cancer and precancer screening studies. British Dental Journal
2002;192(March (6)):340–4 [discussion 32].
10] McIntosh L, McCullough MJ,  Farah CS. The assessment of diffused light illumi-
nation and acetic acid rinse (Microlux/DL) in the visualisation of oral mucosal
lesions. Oral Oncology 2009;45(December (12)):e227–31.
11] Farah CS, McCullough MJ.  A pilot case control study on the efﬁcacy of acetic
acid  wash and chemiluminescent illumination (ViziLite) in the visualisation of
oral mucosal white lesions. Oral Oncology 2007;43(September (8)):820–4.
12] Farah CS, McIntosh L, Georgio A, McCullough MJ.  The efﬁcacy of tissue autoﬂuo-
rescence image (VELScope) in the visualization of oral mucosal lesions. Head
and  Neck 2012;34:856–62.
13] Lingen MW,  Kalmar JR, Karrison T, Speight PM.  Critical evaluation of diagnostic
aids  for the detection of oral cancer. Oral Oncology 2008;44(January (1)):10–22.
14] Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examina-
tion and lesion diagnosis: a systematic review of the literature. Journal of the
American Dental Association 2008;139(July (7)):896–905.
15] Rethman MP, Carpenter W,  Cohen EE, Epstein J, Evans CA, Flaitz CM,
et al. Evidence-based clinical recommendations regarding screening for
oral  squamous cell carcinomas. Journal of the American Dental Association
2010;141(May (5)):509–20.
16] Brocklehurst P, Kujan O, Glenny AM,  Oliver R, Sloan P, Ogden G, et al. Screening
programmes for the early detection and prevention of oral cancer. Cochrane
Database of Systematic Reviews 2010;(11):CD004150.
17] Ramadas K, Sankaranarayanan R, Jacob BJ, Thomas G, Somanathan T, Mahe C,
et  al. Interim results from a cluster randomized controlled oral cancer screening
trial in Kerala, India. Oral Oncology 2003;39(September (6)):580–8.
18] Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B,
et  al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-
randomised controlled trial. Lancet 2005;365(June (9475)):1927–33.
19] Kujan O, Glenny AM,  Duxbury J, Thakker N, Sloan P. Evaluation of screening
strategies for improving oral cancer mortality: a Cochrane systematic review.
Journal of Dental Education 2005;69(February (2)):255–65 [evaluation studies
review].
20] Speight PM, Palmer S, Moles DR, Downer MC,  Smith DH, Henriksson M, et al.
The cost-effectiveness of screening for oral cancer in primary care. Health Tech-
nology Assessment 2006;10(April (14)):1–144 [iii–iv].21] Shuman AG, Entezami P, Chernin AS, Wallace NE, Taylor JM,  Hogikyan ND.
Demographics and efﬁcacy of head and neck cancer screening. Otolaryngology
–  Head and Neck Surgery 2010;143(September (3)):353–60.
22] Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M,  Odell E,
et  al. Factors predicting malignant transformation in oral potentially malignant
f Canc
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[P.J. Ford, C.S. Farah / Journal o
disorders among patients accrued over a 10-year period in South East England.
Journal of Oral Pathology and Medicine 2011;40(July):677–83.
23] Gourin CG, Kaboli KC, Blume EJ, Nance MA,  Koch WM.  Characteristics of par-
ticipants in a free oral, head and neck cancer screening program. Laryngoscope
2009;119(April (4)):679–82.
24] Conway DI, Petticrew M,  Marlborough H, Berthiller J, Hashibe M,  Macpher-
son LM.  Socioeconomic inequalities and oral cancer risk: a systematic review
and  meta-analysis of case-control studies. International Journal of Cancer
2008;122(June (12)):2811–9.
25] Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G,
Mathew B, et al. Cost-effectiveness of oral cancer screening: results from a
cluster randomized controlled trial in India. Bulletin of the World Health Orga-
nization 2009;87(March (3)):200–6.
26] Auluck A, Hislop G, Poh C, Zhang L, Rosin MP.  Areca nut and betel quid chewing
among South Asian immigrants to Western countries and its implications for
oral  cancer screening. Rural Remote Health 2009;9(April–June (2)):1118.
27] Klassen AC, Juon HS, Alberg AJ, Reid BC, Meissner HI. Opportunities for oral
cancer screening among older African-American women. Preventive Medicine
2003;37(November (5)):499–506.
28] Cruz GD, Shulman LC, Kumar JV, Salazar CR. The cultural and social con-
text of oral and pharyngeal cancer risk and control among Hispanics in New
York. Journal of Health Care for the Poor and Underserved 2007;18(November
(4)):833–46.
29] Roder D, Currow D. Cancer in aboriginal and Torres Strait Islander people of
Australia. Asian Paciﬁc Journal of Cancer Prevention 2009;10(5):729–33.
30] Mathew B, Sankaranarayanan R, Sunilkumar KB, Kuruvila B, Pisani P, Nair MK.
Reproducibility and validity of oral visual inspection by trained health work-
ers  in the detection of oral precancer and cancer. British Journal of Cancer
1997;76(3):390–4.
31] Netuveli G, Sheiham A, Watt RG. Does the ‘inverse screening law’ apply to oral
cancer screening and regular dental check-ups? Journal of Medical Screening
2006;13(1):47–50.
32] Carter LM,  Ogden GR. Oral cancer awareness of general medical and general
dental practitioners. British Dental Journal 2007;203(September (5)):E10 [dis-
cussion 248–249].
33] Nicotera G, Di Stasio SM,  Angelillo IF. Knowledge and behaviors of primary care
physicians on oral cancer in Italy. Oral Oncology 2004;40(May (5)):490–5.
34] Wade J, Smith H, Hankins M,  Llewellyn C. Conducting oral examinations
for cancer in general practice: what are the barriers? Family Practice
2010;27(February (1)):77–84.
35] Hollows P, McAndrew PG, Perini MG.  Delays in the referral and treatment of oral
squamous cell carcinoma. British Dental Journal 2000;188(March (5)):262–5.
36] Horowitz AM,  Canto MT,  Child WL.  Maryland adults’ perspectives on oral cancer
prevention and early detection. Journal of the American Dental Association
2002;133(August (8)):1058–63.
37] McLeod NM, Saeed NR, Ali EA. Oral cancer: delays in referral and diagnosis
persist. British Dental Journal 2005;198(JUne (11)):681–4.
38] Schnetler JF. Oral cancer diagnosis and delays in referral. British Journal of Oral
and Maxillofacial Surgery 1992;30(August (4)):210–3.
39] Scott SE, Rizvi K, Grunfeld EA, McGurk M.  Pilot study to estimate the accuracy of
mouth self-examination in an at-risk group. Head and Neck 2010;32(October
(10)):1393–401.
40] Newton JT. Interdisciplinary health promotion: a call for theory-based inter-
ventions drawing on the skills of multiple disciplines. Community Dentistry
and  Oral Epidemiology 2012;40(October (Suppl. 2)):49–54.
41] Walter F, Webster A, Scott S, Emery J. The Andersen model of total patient
delay: a systematic review of its application in cancer diagnosis. Journal of
Health Services Research and Policy 2012;17(April (2)):110–8.
42] Andersen BL, Cacioppo JT. Delay in seeking a cancer diagnosis: delay stages and
psychophysiological comparison processes. British Journal of Social Psychology
1995;34(March (Pt 1)):33–52.
43] Brocklehurst PR, Baker SR, Speight PM.  A qualitative study examining the expe-
rience of primary care dentists in the detection and management of potentially
malignant lesions. 1. Factors inﬂuencing detection and the decision to refer.
British Dental Journal 2010;208(January (2)):E3 [discussion 72–73].
44] Scott SE, Grunfeld EA, Auyeung V, McGurk M.  Barriers and triggers to seeking
help for potentially malignant oral symptoms: implications for interventions.
Journal of Public Health Dentistry 2009;69(Winter (1)):34–40.
45] Scott SE, McGurk M,  Grunfeld EA. The process of symptom appraisal: cognitive
and emotional responses to detecting potentially malignant oral symptoms.
Journal of Psychosomatic Research 2006;62:621–30.
46] Friedman LC, Kalidas M, Elledge R, Dulay MF,  Romero C, Chang J, et al. Medical
and psychosocial predictors of delay in seeking medical consultation for breast
symptoms in women  in a public sector setting. Journal of Behavioral Medicine
2006;29(August (4)):327–34.
47] Grant E, Silver K, Bauld L, Day R, Warnakulasuriya S. The experiences of young
oral cancer patients in Scotland: symptom recognition and delays in seeking
professional help. British Dental Journal 2010;208(May (10)):465–71.
[
[er Policy 1 (2013) e2– e7 e7
48] Hu TW,  Cooke M,  McCarthy A. A qualitative study of the experience of
oral  cancer among Taiwanese men. International Journal of Nursing Practice
2009;15(August (4)):326–33.
49] Allison P, Franco E, Black M,  Feine J. The role of professional diagnostic
delays in the prognosis of upper aerodigestive tract carcinoma. Oral Oncology
1998;34(March (2)):147–53.
50] McGurk M,  Scott SE. The reality of identifying early oral cancer in the general
dental practice. British Dental Journal 2010;208(April (8)):347–51.
51] Onizawa K, Nishihara K, Yamagata K, Yusa H, Yanagawa T, Yoshida H. Fac-
tors associated with diagnostic delay of oral squamous cell carcinoma. Oral
Oncology 2003;39(December (8)):781–8.
52] Brocklehurst PR, Baker SR, Speight PM.  Factors which determine the referral of
potentially malignant disorders by primary care dentists. Journal of Dentistry
2010;38(July (7)):569–78.
53] Brocklehurst PR, Baker SR, Speight PM.  A qualitative study examining the expe-
rience of primary care dentists in the detection and management of potentially
malignant lesions. 2. Mechanics of the referral and patient communication.
British Dental Journal 2010;208(January (2)):E4 [discussion 74–75].
54] Lopez-Jornet P, Camacho-Alonso F, Molina-Minano F. Knowledge and attitudes
about oral cancer among dentists in Spain. Journal of Evaluation in Clinical
Practice 2010;16(February (1)):129–33.
55] Wildt J, Bundgaard T, Bentzen SM.  Delay in the diagnosis of oral squamous
cell  carcinoma. Clinical Otolaryngology and Allied Sciences 1995;20(February
(1)):21–5.
56] Scully C, Newman L, Bagan JV. The role of the dental team in preventing
and diagnosing cancer: 3. oral cancer diagnosis and screening. Dental Update
2005;32(July–August (6)):326–8 [31–32, 35–37].
57] Greenwood M,  Lowry RJ. Primary care clinicians’ knowledge of oral cancer: a
study of dentists and doctors in the North East of England. British Dental Journal
2001;191(November (9)):510–2.
58] Bruun JP. Time lapse by diagnosis of oral cancer. Oral Surgery, Oral Medicine,
Oral Pathology 1976;42(August (2)):139–49.
59] Epstein JB, Sciubba JJ, Banasek TE, Hay LJ. Failure to diagnose and delayed diag-
nosis of cancer: medicolegal issues. Journal of the American Dental Association
2009;140(December (12)):1494–503.
60] Bartholomew LK, Mullen PD. Five roles for using theory and evidence in the
design and testing of behavior change interventions. Journal of Public Health
Dentistry 2011;71(Winter (Suppl. 1)):S20–33.
61] Rogers SN, Vedpathak SV, Lowe D. Reasons for delayed presentation in oral
and  oropharyngeal cancer: the patients perspective. British Journal of Oral and
Maxillofacial Surgery 2010;49(July):349–53.
62] Scott SE, Weinman J, Grunfeld EA. Developing ways to encourage early detec-
tion and presentation of oral cancer: what do high-risk individuals think?
Psychology & Health 2011;26(10):1392–405.
63] Eadie D, MacKintosh AM,  MacAskill S, Brown A. Development and evaluation of
an early detection intervention for mouth cancer using a mass media approach.
British Journal of Cancer 2009;101(December (Suppl. 2)):S73–9.
64] Jedele JM,  Ismail AI. Evaluation of a multifaceted social marketing campaign
to  increase awareness of and screening for oral cancer in African Americans.
Community Dentistry and Oral Epidemiology 2010;38(August (4)):371–82.
65] Petti S, Scully C. Oral cancer knowledge and awareness: primary and secondary
effects of an information leaﬂet. Oral Oncology 2007;43(April (4)):408–15.
66] Lingen MW.  Direct-to-consumer advertising for oral cancer screening devices.
Oral  Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics
2009;107(March (3)):299–300.
67] Herlitz J, Hartford M, Blohm M,  Karlson BW,  Ekstrom L, Risenfors M, et al. Effect
of  a media campaign on delay times and ambulance use in suspected acute
myocardial infarction. American Journal of Cardiology 1989;64(July (1)):90–3.
68] McCann PJ, Sweeney MP, Gibson J, Bagg J. Training in oral disease, diagnosis
and treatment for medical students and doctors in the United Kingdom. British
Journal of Oral and Maxillofacial Surgery 2005;43(February (1)):61–4.
69] Horowitz AM, Drury TF, Goodman HS, Yellowitz JA. Oral pharyngeal cancer
prevention and early detection. Dentists’ opinions and practices. Journal of the
American Dental Association 2000;131(April (4)):453–62.
70] Horowitz AM,  Siriphant P, Sheikh A, Child WL.  Perspectives of Mary-
land dentists on oral cancer. Journal of the American Dental Association
2001;132(January (1)):65–72.
71] Macpherson LM,  McCann MF,  Gibson J, Binnie VI, Stephen KW.  The role of pri-
mary healthcare professionals in oral cancer prevention and detection. British
Dental Journal 2003;195(September (5)):277–81 [discussion 63].
72] Santos LC, Batista Ode M,  Cangussu MC.  Characterization of oral cancer diag-
nostic delay in the state of Alagoas. Brazilian Journal of Otorhinolaryngology
2010;76(August (4)):416–22.73] NACOH. Healthy mouths healthy lives: Australia’s national oral health plan
2004–2013. Adelaide: National Advisory Committee on Oral Health; 2004.
74] Underwood SM,  Hoskins D, Cummins T, Morris K, Williams A. Obstacles to can-
cer  care: focus on the economically disadvantaged. Oncology Nursing Forum
1994;21(January–February (1)):47–52.
